.png?width=1800&height=600&name=MicrosoftTeams-image%20(82).png)
2 min read
Hasselt, Belgium, December 14, 2015 – Complix NV, a biopharmaceutical company developing a pipeline of transformative protein therapeutics, called…
4 min read
To acquire biologics manufacturing facility and capabilities from XOMA Acquires rights to Selexis cell line development technology Purchases an…
2 min read
TURKU - FINLAND 03 November 2015 – Faron Pharmaceuticals Oy (”Faron”), the clinical stage biopharmaceutical company, announced today it has entered…
1 min read
Selexis Will Apply the SURE CHO-Mplus Libraries™ to Achieve OptimalExpression Results with a Difficult-to-Express Protein
2 min read
Geneva, Switzerland, May 20, 2015 -- Merus B.V., a leader in developing best-in-class bispecific antibody therapeutics to treat cancer patients and…
1 min read
Geneva, Switzerland, January 8, 2015 – Selexis SA, a serial innovation company with proven technologies for characterized mammalian Research Cell…
1 min read
Geneva, Switzerland, December 9, 2014 – Selexis SA, a serial innovation company with proven technologies for biologic drug discovery and mammalian…
2 min read
Preliminary Data from the Successful Proof-of-Concept Program Published in the June Issue of BioProcess International
1 min read
Expansion to Include the Selexis SURE CHO-M Cell Line™
2 min read
Geneva, Switzerland, January 13, 2014 – Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line…
